^
    Back
    Association details:
    Biomarker:MET fusion
    Cancer:Glioblastoma
    Drug:Xalkori (crizotinib) (ALK inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: C4 – Case Studies
    New
    Source:
    Nat Med
    Title:

    Recurrent MET fusion genes represent a drug target in pediatric glioblastoma

    Excerpt:
    Recurrent MET fusion genes represent a drug target in pediatric glioblastoma...
    DOI:
    10.1038/nm.4204